Population-based reference intervals for 48 clinical chemistry and hematology measurands (study group1, n = 143), with 90% CI for the lower and upper limits.
Measurands . | Group . | n . | Lower limit (90% CI) . | Upper limit (90% CI) . |
---|---|---|---|---|
Glucose, mg/dL | All | 143 | 69.1 (67.3–70.8) | 97.3 (95.6–99.0) |
Hemoglobin A1c, % | All | 143 | 4.4 (4.3–4.6) | 5.9 (5.8–5.9) |
BUN,a mg/dL | All | 143 | 7.0 (5.0–8.0) | 22.0 (20.0–25.0) |
Creatinine,b mg/dL | F | 78 | 0.53 (0.51–0.56) | 0.87 (0.85–0.90) |
Creatinine,b mg/dL | M | 64 | 0.70 (0.66–0.74) | 1.22 (1.17–1.25) |
Uric acid,b mg/dL | F | 79 | 2.4 (2.1–2.6) | 5.3 (5.0–5.7) |
Uric acid,a,b mg/dL | M | 64 | 3.7 (3.4–3.9) | 8.0 (7.4–8.6) |
Albumin, g/dL | All | 143 | 3.6 (3.6–3.7) | 4.8 (4.8–4.9) |
Total protein,a g/dL | All | 143 | 6.6 (6.4–6.9)c | 8.5 (8.3–8.7)c |
Bilirubin,a total, mg/dL | All | 142 | 0.15 (0.13–0.17) | 1.33 (1.16–1.51)c |
Bilirubin,a direct, mg/dL | All | 142 | 0.05 (0.05–0.06) | 0.29 (0.24–0.32)c |
Cholesterol,a total, mg/dL | All | 143 | 116.1 (111.4–121.1) | 230.3 (220.8–240.1) |
LDL-cholesterol, mg/dL | All | 143 | 51.8 (45.7–57.8) | 151.5 (145.4–157.6) |
HDL-cholesterol, mg/dL | All | 143 | 28.1 (25.4–30.9) | 72.8 (70.1–75.6) |
Triglyceride,a mg/dL | All | 139 | 31.5 (29.0–35.0) | 157.5 (139.0–177.0)c |
ALT,b IU/L | F | 77 | 13.4 (11.5–15.1) | 31.6 (29.6–33.1) |
ALT,a,b IU/L | M | 64 | 18.6 (17.0–20.8) | 62.2 (56.1–69.3)c |
AST,a IU/L | All | 143 | 11.2 (10.6–11.9) | 29.4 (27.4–31.2)c |
LDH, IU/L | All | 142 | 116 (112–122) | 200 (195–205) |
ALP,a IU/L | All | 143 | 33.9 (31.7–36.2) | 101.4 (94.8–108.4)c |
Amylase,a IU/L | All | 143 | 33.6 (31.3–36.1) | 107.0 (99.7–114.8)c |
Lipase,a IU/L | All | 143 | 73.7 (68.3–79.6) | 259.3 (240.2–280.0)c |
CK,a,b IU/L | F | 77 | 24.7 (22.2–28.0) | 117.4 (101.6–134.6)c |
CK,a,b IU/L | M | 63 | 25.9 (20.6–32.3) | 265.1 (208–348.7)c |
Calcium, mg/dL | All | 142 | 8.7 (8.6–8.8) | 10.4 (10.3–10.5) |
Magnesium, mg/dL | All | 143 | 1.6 (1.5–1.6) | 2.2 (2.1–2.2) |
TSH,a µIU/mL | All | 138 | 0.48 (0.31–0.66) | 3.51 (2.88–3.74)c |
TT3,a ng/dL | All | 141 | 90 (87–93) | 164 (158–170) |
FT3, pg/dL | All | 140 | 272 (266–279) | 396 (390–403) |
FT4, ng/dL | All | 141 | 0.94 (0.91–0.97) | 1.38 (1.35–1.40) |
Insulin,a µIU/mL | All | 143 | 3.6 (3.2–4.0) | 20.5 (18.4–20.8) |
Testosterone,b total, ng/dL | F | 79 | 12.2 (9.5–14.8) | 49.0 (45.5–52.2) |
Testosterone,b total, ng/dL | M | 64 | 183 (137–239) | 777 (713–831) |
PSA, total,a,b ng/mL | All | 63 | 0.22 (0.20–0.27) | 1.42 (1.24–1.73)c |
PSA, free,a,b ng/mL | All | 64 | 0.10 (0.08–0.12) | 0.73 (0.60–0.89)c |
PTH,a pg/mL | All | 143 | 15.4 (13.8–17.2) | 91.1 (81.8–101–5)c |
Erythrocytes,b ×106/µL | F | 79 | 4.0 (3.9–4.1) | 5.1 (5.0–5.2) |
Erythrocytes,b ×106/µL | M | 64 | 4.5 (4.4–4.6) | 5.9 (5.8–6.1) |
Hemoglobin,b g/dL | F | 79 | 11.7 (11.9–11.4) | 14.5 (14.7–14.2) |
Hemoglobin,b g/dL | M | 64 | 13.3 (13.0–13.6) | 17.0 (16.6–17.3) |
Hematocrit,b % | F | 79 | 35.9 (35.2–36.6) | 44.8 (44.1–45.5) |
Hematocrit,b % | M | 64 | 40.6 (39.6–41.5) | 51.0 (50.1–52.0) |
MCH, pg | All | 143 | 25.8 (25.4–26.2) | 31.8 (31.5–32.2) |
MCHC, g/dL | All | 143 | 30.6 (30.3–30.8) | 34.8 (34.5–35.0) |
MCV, fL | All | 143 | 80.7 (79.8–81.6) | 95.6 (94.7–96.5) |
RDW-SD, fL | All | 143 | 35.8 (35.2–36.3) | 45.4 (44.8–46.0) |
WBC,a,b ×103/µL | All | 143 | 3.6 (3.2–4.1) | 9.5 (9.1–10.0) |
Neutrophils,a ×103/µL | All | 143 | 2.1 (2.0–2.3) | 6.2 (5.8–6.6) |
Lymphocytes,a ×103/µL | All | 143 | 1.3 (1.2–1.4) | 3.7 (3.4–3.9) |
Monocytes,a ×103/µL | All | 143 | 0.31 (0.29–0.33) | 0.89 (0.83–0.95)c |
Eosinophils,a ×103/µL | All | 141 | 0.04 (0.03–0.05) | 0.48 (0.40–0.55)c |
Thrombocytes, ×103/µL | All | 143 | 153 (140–160) | 358 (345–370) |
MPV,a fL | All | 143 | 8.9 (8.7–9.1) | 12.6 (12.3–12.8) |
PTC,a % | All | 143 | 0.18 (0.16–0.20) | 0.38 (0.36–0.41)c |
PDW, fL | All | 142 | 9.4 (9.0–9.7) | 16.5 (16.1–17.4) |
P-LCR, % | All | 143 | 14.9 (13.0–16.7) | 45.16 (43.3–47.0) |
Measurands . | Group . | n . | Lower limit (90% CI) . | Upper limit (90% CI) . |
---|---|---|---|---|
Glucose, mg/dL | All | 143 | 69.1 (67.3–70.8) | 97.3 (95.6–99.0) |
Hemoglobin A1c, % | All | 143 | 4.4 (4.3–4.6) | 5.9 (5.8–5.9) |
BUN,a mg/dL | All | 143 | 7.0 (5.0–8.0) | 22.0 (20.0–25.0) |
Creatinine,b mg/dL | F | 78 | 0.53 (0.51–0.56) | 0.87 (0.85–0.90) |
Creatinine,b mg/dL | M | 64 | 0.70 (0.66–0.74) | 1.22 (1.17–1.25) |
Uric acid,b mg/dL | F | 79 | 2.4 (2.1–2.6) | 5.3 (5.0–5.7) |
Uric acid,a,b mg/dL | M | 64 | 3.7 (3.4–3.9) | 8.0 (7.4–8.6) |
Albumin, g/dL | All | 143 | 3.6 (3.6–3.7) | 4.8 (4.8–4.9) |
Total protein,a g/dL | All | 143 | 6.6 (6.4–6.9)c | 8.5 (8.3–8.7)c |
Bilirubin,a total, mg/dL | All | 142 | 0.15 (0.13–0.17) | 1.33 (1.16–1.51)c |
Bilirubin,a direct, mg/dL | All | 142 | 0.05 (0.05–0.06) | 0.29 (0.24–0.32)c |
Cholesterol,a total, mg/dL | All | 143 | 116.1 (111.4–121.1) | 230.3 (220.8–240.1) |
LDL-cholesterol, mg/dL | All | 143 | 51.8 (45.7–57.8) | 151.5 (145.4–157.6) |
HDL-cholesterol, mg/dL | All | 143 | 28.1 (25.4–30.9) | 72.8 (70.1–75.6) |
Triglyceride,a mg/dL | All | 139 | 31.5 (29.0–35.0) | 157.5 (139.0–177.0)c |
ALT,b IU/L | F | 77 | 13.4 (11.5–15.1) | 31.6 (29.6–33.1) |
ALT,a,b IU/L | M | 64 | 18.6 (17.0–20.8) | 62.2 (56.1–69.3)c |
AST,a IU/L | All | 143 | 11.2 (10.6–11.9) | 29.4 (27.4–31.2)c |
LDH, IU/L | All | 142 | 116 (112–122) | 200 (195–205) |
ALP,a IU/L | All | 143 | 33.9 (31.7–36.2) | 101.4 (94.8–108.4)c |
Amylase,a IU/L | All | 143 | 33.6 (31.3–36.1) | 107.0 (99.7–114.8)c |
Lipase,a IU/L | All | 143 | 73.7 (68.3–79.6) | 259.3 (240.2–280.0)c |
CK,a,b IU/L | F | 77 | 24.7 (22.2–28.0) | 117.4 (101.6–134.6)c |
CK,a,b IU/L | M | 63 | 25.9 (20.6–32.3) | 265.1 (208–348.7)c |
Calcium, mg/dL | All | 142 | 8.7 (8.6–8.8) | 10.4 (10.3–10.5) |
Magnesium, mg/dL | All | 143 | 1.6 (1.5–1.6) | 2.2 (2.1–2.2) |
TSH,a µIU/mL | All | 138 | 0.48 (0.31–0.66) | 3.51 (2.88–3.74)c |
TT3,a ng/dL | All | 141 | 90 (87–93) | 164 (158–170) |
FT3, pg/dL | All | 140 | 272 (266–279) | 396 (390–403) |
FT4, ng/dL | All | 141 | 0.94 (0.91–0.97) | 1.38 (1.35–1.40) |
Insulin,a µIU/mL | All | 143 | 3.6 (3.2–4.0) | 20.5 (18.4–20.8) |
Testosterone,b total, ng/dL | F | 79 | 12.2 (9.5–14.8) | 49.0 (45.5–52.2) |
Testosterone,b total, ng/dL | M | 64 | 183 (137–239) | 777 (713–831) |
PSA, total,a,b ng/mL | All | 63 | 0.22 (0.20–0.27) | 1.42 (1.24–1.73)c |
PSA, free,a,b ng/mL | All | 64 | 0.10 (0.08–0.12) | 0.73 (0.60–0.89)c |
PTH,a pg/mL | All | 143 | 15.4 (13.8–17.2) | 91.1 (81.8–101–5)c |
Erythrocytes,b ×106/µL | F | 79 | 4.0 (3.9–4.1) | 5.1 (5.0–5.2) |
Erythrocytes,b ×106/µL | M | 64 | 4.5 (4.4–4.6) | 5.9 (5.8–6.1) |
Hemoglobin,b g/dL | F | 79 | 11.7 (11.9–11.4) | 14.5 (14.7–14.2) |
Hemoglobin,b g/dL | M | 64 | 13.3 (13.0–13.6) | 17.0 (16.6–17.3) |
Hematocrit,b % | F | 79 | 35.9 (35.2–36.6) | 44.8 (44.1–45.5) |
Hematocrit,b % | M | 64 | 40.6 (39.6–41.5) | 51.0 (50.1–52.0) |
MCH, pg | All | 143 | 25.8 (25.4–26.2) | 31.8 (31.5–32.2) |
MCHC, g/dL | All | 143 | 30.6 (30.3–30.8) | 34.8 (34.5–35.0) |
MCV, fL | All | 143 | 80.7 (79.8–81.6) | 95.6 (94.7–96.5) |
RDW-SD, fL | All | 143 | 35.8 (35.2–36.3) | 45.4 (44.8–46.0) |
WBC,a,b ×103/µL | All | 143 | 3.6 (3.2–4.1) | 9.5 (9.1–10.0) |
Neutrophils,a ×103/µL | All | 143 | 2.1 (2.0–2.3) | 6.2 (5.8–6.6) |
Lymphocytes,a ×103/µL | All | 143 | 1.3 (1.2–1.4) | 3.7 (3.4–3.9) |
Monocytes,a ×103/µL | All | 143 | 0.31 (0.29–0.33) | 0.89 (0.83–0.95)c |
Eosinophils,a ×103/µL | All | 141 | 0.04 (0.03–0.05) | 0.48 (0.40–0.55)c |
Thrombocytes, ×103/µL | All | 143 | 153 (140–160) | 358 (345–370) |
MPV,a fL | All | 143 | 8.9 (8.7–9.1) | 12.6 (12.3–12.8) |
PTC,a % | All | 143 | 0.18 (0.16–0.20) | 0.38 (0.36–0.41)c |
PDW, fL | All | 142 | 9.4 (9.0–9.7) | 16.5 (16.1–17.4) |
P-LCR, % | All | 143 | 14.9 (13.0–16.7) | 45.16 (43.3–47.0) |
Abbreviations: F, females; M, males; BUN, blood urea nitrogen; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; CK, creatine kinase; TSH, thyroid-stimulating hormone; TT3, total triiodothyronine; FT3, free triiodothyronine; FT4, free thyroxine; PSA, prostrate-specific antigen; PTH, parathyroid hormone; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; RDW, red cell distribution width; WBC, white blood cell; MPV, mean platelet volume; PTC, plateletcrit; PDW, platelet distribution width; P-LCR, platelet-large cell ratio.
Log-transformed.
Bootstrap techniques.
Did not fully fulfil the criteria of 95% CI < 0.2 × range of the RI.
Population-based reference intervals for 48 clinical chemistry and hematology measurands (study group1, n = 143), with 90% CI for the lower and upper limits.
Measurands . | Group . | n . | Lower limit (90% CI) . | Upper limit (90% CI) . |
---|---|---|---|---|
Glucose, mg/dL | All | 143 | 69.1 (67.3–70.8) | 97.3 (95.6–99.0) |
Hemoglobin A1c, % | All | 143 | 4.4 (4.3–4.6) | 5.9 (5.8–5.9) |
BUN,a mg/dL | All | 143 | 7.0 (5.0–8.0) | 22.0 (20.0–25.0) |
Creatinine,b mg/dL | F | 78 | 0.53 (0.51–0.56) | 0.87 (0.85–0.90) |
Creatinine,b mg/dL | M | 64 | 0.70 (0.66–0.74) | 1.22 (1.17–1.25) |
Uric acid,b mg/dL | F | 79 | 2.4 (2.1–2.6) | 5.3 (5.0–5.7) |
Uric acid,a,b mg/dL | M | 64 | 3.7 (3.4–3.9) | 8.0 (7.4–8.6) |
Albumin, g/dL | All | 143 | 3.6 (3.6–3.7) | 4.8 (4.8–4.9) |
Total protein,a g/dL | All | 143 | 6.6 (6.4–6.9)c | 8.5 (8.3–8.7)c |
Bilirubin,a total, mg/dL | All | 142 | 0.15 (0.13–0.17) | 1.33 (1.16–1.51)c |
Bilirubin,a direct, mg/dL | All | 142 | 0.05 (0.05–0.06) | 0.29 (0.24–0.32)c |
Cholesterol,a total, mg/dL | All | 143 | 116.1 (111.4–121.1) | 230.3 (220.8–240.1) |
LDL-cholesterol, mg/dL | All | 143 | 51.8 (45.7–57.8) | 151.5 (145.4–157.6) |
HDL-cholesterol, mg/dL | All | 143 | 28.1 (25.4–30.9) | 72.8 (70.1–75.6) |
Triglyceride,a mg/dL | All | 139 | 31.5 (29.0–35.0) | 157.5 (139.0–177.0)c |
ALT,b IU/L | F | 77 | 13.4 (11.5–15.1) | 31.6 (29.6–33.1) |
ALT,a,b IU/L | M | 64 | 18.6 (17.0–20.8) | 62.2 (56.1–69.3)c |
AST,a IU/L | All | 143 | 11.2 (10.6–11.9) | 29.4 (27.4–31.2)c |
LDH, IU/L | All | 142 | 116 (112–122) | 200 (195–205) |
ALP,a IU/L | All | 143 | 33.9 (31.7–36.2) | 101.4 (94.8–108.4)c |
Amylase,a IU/L | All | 143 | 33.6 (31.3–36.1) | 107.0 (99.7–114.8)c |
Lipase,a IU/L | All | 143 | 73.7 (68.3–79.6) | 259.3 (240.2–280.0)c |
CK,a,b IU/L | F | 77 | 24.7 (22.2–28.0) | 117.4 (101.6–134.6)c |
CK,a,b IU/L | M | 63 | 25.9 (20.6–32.3) | 265.1 (208–348.7)c |
Calcium, mg/dL | All | 142 | 8.7 (8.6–8.8) | 10.4 (10.3–10.5) |
Magnesium, mg/dL | All | 143 | 1.6 (1.5–1.6) | 2.2 (2.1–2.2) |
TSH,a µIU/mL | All | 138 | 0.48 (0.31–0.66) | 3.51 (2.88–3.74)c |
TT3,a ng/dL | All | 141 | 90 (87–93) | 164 (158–170) |
FT3, pg/dL | All | 140 | 272 (266–279) | 396 (390–403) |
FT4, ng/dL | All | 141 | 0.94 (0.91–0.97) | 1.38 (1.35–1.40) |
Insulin,a µIU/mL | All | 143 | 3.6 (3.2–4.0) | 20.5 (18.4–20.8) |
Testosterone,b total, ng/dL | F | 79 | 12.2 (9.5–14.8) | 49.0 (45.5–52.2) |
Testosterone,b total, ng/dL | M | 64 | 183 (137–239) | 777 (713–831) |
PSA, total,a,b ng/mL | All | 63 | 0.22 (0.20–0.27) | 1.42 (1.24–1.73)c |
PSA, free,a,b ng/mL | All | 64 | 0.10 (0.08–0.12) | 0.73 (0.60–0.89)c |
PTH,a pg/mL | All | 143 | 15.4 (13.8–17.2) | 91.1 (81.8–101–5)c |
Erythrocytes,b ×106/µL | F | 79 | 4.0 (3.9–4.1) | 5.1 (5.0–5.2) |
Erythrocytes,b ×106/µL | M | 64 | 4.5 (4.4–4.6) | 5.9 (5.8–6.1) |
Hemoglobin,b g/dL | F | 79 | 11.7 (11.9–11.4) | 14.5 (14.7–14.2) |
Hemoglobin,b g/dL | M | 64 | 13.3 (13.0–13.6) | 17.0 (16.6–17.3) |
Hematocrit,b % | F | 79 | 35.9 (35.2–36.6) | 44.8 (44.1–45.5) |
Hematocrit,b % | M | 64 | 40.6 (39.6–41.5) | 51.0 (50.1–52.0) |
MCH, pg | All | 143 | 25.8 (25.4–26.2) | 31.8 (31.5–32.2) |
MCHC, g/dL | All | 143 | 30.6 (30.3–30.8) | 34.8 (34.5–35.0) |
MCV, fL | All | 143 | 80.7 (79.8–81.6) | 95.6 (94.7–96.5) |
RDW-SD, fL | All | 143 | 35.8 (35.2–36.3) | 45.4 (44.8–46.0) |
WBC,a,b ×103/µL | All | 143 | 3.6 (3.2–4.1) | 9.5 (9.1–10.0) |
Neutrophils,a ×103/µL | All | 143 | 2.1 (2.0–2.3) | 6.2 (5.8–6.6) |
Lymphocytes,a ×103/µL | All | 143 | 1.3 (1.2–1.4) | 3.7 (3.4–3.9) |
Monocytes,a ×103/µL | All | 143 | 0.31 (0.29–0.33) | 0.89 (0.83–0.95)c |
Eosinophils,a ×103/µL | All | 141 | 0.04 (0.03–0.05) | 0.48 (0.40–0.55)c |
Thrombocytes, ×103/µL | All | 143 | 153 (140–160) | 358 (345–370) |
MPV,a fL | All | 143 | 8.9 (8.7–9.1) | 12.6 (12.3–12.8) |
PTC,a % | All | 143 | 0.18 (0.16–0.20) | 0.38 (0.36–0.41)c |
PDW, fL | All | 142 | 9.4 (9.0–9.7) | 16.5 (16.1–17.4) |
P-LCR, % | All | 143 | 14.9 (13.0–16.7) | 45.16 (43.3–47.0) |
Measurands . | Group . | n . | Lower limit (90% CI) . | Upper limit (90% CI) . |
---|---|---|---|---|
Glucose, mg/dL | All | 143 | 69.1 (67.3–70.8) | 97.3 (95.6–99.0) |
Hemoglobin A1c, % | All | 143 | 4.4 (4.3–4.6) | 5.9 (5.8–5.9) |
BUN,a mg/dL | All | 143 | 7.0 (5.0–8.0) | 22.0 (20.0–25.0) |
Creatinine,b mg/dL | F | 78 | 0.53 (0.51–0.56) | 0.87 (0.85–0.90) |
Creatinine,b mg/dL | M | 64 | 0.70 (0.66–0.74) | 1.22 (1.17–1.25) |
Uric acid,b mg/dL | F | 79 | 2.4 (2.1–2.6) | 5.3 (5.0–5.7) |
Uric acid,a,b mg/dL | M | 64 | 3.7 (3.4–3.9) | 8.0 (7.4–8.6) |
Albumin, g/dL | All | 143 | 3.6 (3.6–3.7) | 4.8 (4.8–4.9) |
Total protein,a g/dL | All | 143 | 6.6 (6.4–6.9)c | 8.5 (8.3–8.7)c |
Bilirubin,a total, mg/dL | All | 142 | 0.15 (0.13–0.17) | 1.33 (1.16–1.51)c |
Bilirubin,a direct, mg/dL | All | 142 | 0.05 (0.05–0.06) | 0.29 (0.24–0.32)c |
Cholesterol,a total, mg/dL | All | 143 | 116.1 (111.4–121.1) | 230.3 (220.8–240.1) |
LDL-cholesterol, mg/dL | All | 143 | 51.8 (45.7–57.8) | 151.5 (145.4–157.6) |
HDL-cholesterol, mg/dL | All | 143 | 28.1 (25.4–30.9) | 72.8 (70.1–75.6) |
Triglyceride,a mg/dL | All | 139 | 31.5 (29.0–35.0) | 157.5 (139.0–177.0)c |
ALT,b IU/L | F | 77 | 13.4 (11.5–15.1) | 31.6 (29.6–33.1) |
ALT,a,b IU/L | M | 64 | 18.6 (17.0–20.8) | 62.2 (56.1–69.3)c |
AST,a IU/L | All | 143 | 11.2 (10.6–11.9) | 29.4 (27.4–31.2)c |
LDH, IU/L | All | 142 | 116 (112–122) | 200 (195–205) |
ALP,a IU/L | All | 143 | 33.9 (31.7–36.2) | 101.4 (94.8–108.4)c |
Amylase,a IU/L | All | 143 | 33.6 (31.3–36.1) | 107.0 (99.7–114.8)c |
Lipase,a IU/L | All | 143 | 73.7 (68.3–79.6) | 259.3 (240.2–280.0)c |
CK,a,b IU/L | F | 77 | 24.7 (22.2–28.0) | 117.4 (101.6–134.6)c |
CK,a,b IU/L | M | 63 | 25.9 (20.6–32.3) | 265.1 (208–348.7)c |
Calcium, mg/dL | All | 142 | 8.7 (8.6–8.8) | 10.4 (10.3–10.5) |
Magnesium, mg/dL | All | 143 | 1.6 (1.5–1.6) | 2.2 (2.1–2.2) |
TSH,a µIU/mL | All | 138 | 0.48 (0.31–0.66) | 3.51 (2.88–3.74)c |
TT3,a ng/dL | All | 141 | 90 (87–93) | 164 (158–170) |
FT3, pg/dL | All | 140 | 272 (266–279) | 396 (390–403) |
FT4, ng/dL | All | 141 | 0.94 (0.91–0.97) | 1.38 (1.35–1.40) |
Insulin,a µIU/mL | All | 143 | 3.6 (3.2–4.0) | 20.5 (18.4–20.8) |
Testosterone,b total, ng/dL | F | 79 | 12.2 (9.5–14.8) | 49.0 (45.5–52.2) |
Testosterone,b total, ng/dL | M | 64 | 183 (137–239) | 777 (713–831) |
PSA, total,a,b ng/mL | All | 63 | 0.22 (0.20–0.27) | 1.42 (1.24–1.73)c |
PSA, free,a,b ng/mL | All | 64 | 0.10 (0.08–0.12) | 0.73 (0.60–0.89)c |
PTH,a pg/mL | All | 143 | 15.4 (13.8–17.2) | 91.1 (81.8–101–5)c |
Erythrocytes,b ×106/µL | F | 79 | 4.0 (3.9–4.1) | 5.1 (5.0–5.2) |
Erythrocytes,b ×106/µL | M | 64 | 4.5 (4.4–4.6) | 5.9 (5.8–6.1) |
Hemoglobin,b g/dL | F | 79 | 11.7 (11.9–11.4) | 14.5 (14.7–14.2) |
Hemoglobin,b g/dL | M | 64 | 13.3 (13.0–13.6) | 17.0 (16.6–17.3) |
Hematocrit,b % | F | 79 | 35.9 (35.2–36.6) | 44.8 (44.1–45.5) |
Hematocrit,b % | M | 64 | 40.6 (39.6–41.5) | 51.0 (50.1–52.0) |
MCH, pg | All | 143 | 25.8 (25.4–26.2) | 31.8 (31.5–32.2) |
MCHC, g/dL | All | 143 | 30.6 (30.3–30.8) | 34.8 (34.5–35.0) |
MCV, fL | All | 143 | 80.7 (79.8–81.6) | 95.6 (94.7–96.5) |
RDW-SD, fL | All | 143 | 35.8 (35.2–36.3) | 45.4 (44.8–46.0) |
WBC,a,b ×103/µL | All | 143 | 3.6 (3.2–4.1) | 9.5 (9.1–10.0) |
Neutrophils,a ×103/µL | All | 143 | 2.1 (2.0–2.3) | 6.2 (5.8–6.6) |
Lymphocytes,a ×103/µL | All | 143 | 1.3 (1.2–1.4) | 3.7 (3.4–3.9) |
Monocytes,a ×103/µL | All | 143 | 0.31 (0.29–0.33) | 0.89 (0.83–0.95)c |
Eosinophils,a ×103/µL | All | 141 | 0.04 (0.03–0.05) | 0.48 (0.40–0.55)c |
Thrombocytes, ×103/µL | All | 143 | 153 (140–160) | 358 (345–370) |
MPV,a fL | All | 143 | 8.9 (8.7–9.1) | 12.6 (12.3–12.8) |
PTC,a % | All | 143 | 0.18 (0.16–0.20) | 0.38 (0.36–0.41)c |
PDW, fL | All | 142 | 9.4 (9.0–9.7) | 16.5 (16.1–17.4) |
P-LCR, % | All | 143 | 14.9 (13.0–16.7) | 45.16 (43.3–47.0) |
Abbreviations: F, females; M, males; BUN, blood urea nitrogen; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; CK, creatine kinase; TSH, thyroid-stimulating hormone; TT3, total triiodothyronine; FT3, free triiodothyronine; FT4, free thyroxine; PSA, prostrate-specific antigen; PTH, parathyroid hormone; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; RDW, red cell distribution width; WBC, white blood cell; MPV, mean platelet volume; PTC, plateletcrit; PDW, platelet distribution width; P-LCR, platelet-large cell ratio.
Log-transformed.
Bootstrap techniques.
Did not fully fulfil the criteria of 95% CI < 0.2 × range of the RI.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.